Search

Out of stock

Buy Accrufer (ferric maltol) Online

DISEASE INDICATIONS: Iron deficiency

MANUFACTURER: Shield Therapeutics

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Swissmedic (CH)

Accrufer, with the generic name ferric maltol, is a prescription medication used in the treatment of iron deficiency anemia in adults. It is classified as an iron replacement therapy and is designed to help raise and maintain healthy levels of iron in the body.

This product is currently out of stock and unavailable.

Compare

Accrufer, with the generic name ferric maltol, is a prescription medication used in the treatment of iron deficiency anemia in adults. It is classified as an iron replacement therapy and is designed to help raise and maintain healthy levels of iron in the body. Here is a detailed description of Accrufer:

Drug Class:

Accrufer belongs to the class of medications known as iron supplements. It is a form of oral iron therapy used to replenish iron stores in the body.

Indications:

Accrufer is primarily indicated for the treatment of iron deficiency anemia in adults. Iron deficiency anemia occurs when there is an insufficient amount of iron in the body, leading to reduced production of red blood cells and hemoglobin.

Mechanism of Action:

Ferric maltol, the active ingredient in Accrufer, provides a source of iron that the body can absorb and use to produce red blood cells and hemoglobin. Hemoglobin is a protein in red blood cells that carries oxygen from the lungs to various tissues in the body. By increasing iron levels, Accrufer helps improve the oxygen-carrying capacity of the blood.

Dosage and Administration:

The dosage of Accrufer is typically determined by a healthcare provider based on the severity of iron deficiency anemia and individual patient factors. It is taken orally in capsule form and is usually administered with or without food, depending on the healthcare provider’s instructions.

Effectiveness:

Accrufer is effective in replenishing iron stores and increasing hemoglobin levels in individuals with iron deficiency anemia. Improvement in symptoms such as fatigue, weakness, and paleness is often observed with successful treatment.

Side Effects:

Common side effects of Accrufer may include diarrhea, constipation, nausea, abdominal pain, and changes in stool color. These side effects are generally mild and temporary. Serious side effects are rare but can occur, and individuals should consult their healthcare provider if they experience any adverse reactions.

Contraindications:

Accrufer is contraindicated in individuals with a known hypersensitivity to ferric maltol or any of its components. It should not be used in cases of iron overload conditions such as hemochromatosis.

Consultation with a Healthcare Provider:

Before starting Accrufer, individuals should consult with their healthcare provider to determine the underlying cause of their anemia and to assess if this medication is an appropriate treatment option. Regular monitoring and follow-up are essential during treatment with Accrufer to track progress and manage potential side effects.

Accrufer offers an important treatment option for individuals with iron deficiency anemia, a condition that can result in fatigue, weakness, and other symptoms. Its use should always be under the guidance and supervision of qualified healthcare professionals who can assess the individual’s specific medical condition and needs.

Package

56 capsules of 30 mg

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Ultomiris (ravulizumab) Online

(0 Reviews)
MANUFACTURER: Alexion Pharmaceuticals USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Ultomiris, known by its generic name Ravulizumab, is a medication used to treat two rare and life-threatening blood disorders, namely paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).

Buy Cablivi (caplacizumab) Online

$4,125.96
(0 Reviews)
DISEASE INDICATIONS: Acquired thrombotic thrombocytopenic purpura (aTTP) MANUFACTURER: Ablynx NV USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Cablivi, with its active ingredient caplacizumab, is a prescription medication used in the treatment of a rare and serious medical condition known as acquired thrombotic thrombocytopenic purpura (aTTP).

Buy Inrebic (fedratinib) Online

$5,242.36
(0 Reviews)
DISEASE INDICATIONS: Myelofibrosis MANUFACTURER: Impact Biomedicines, Inc. USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Inrebic, known by its generic name Fedratinib, is a medication used to treat certain rare bone marrow disorders, specifically myelofibrosis.

Buy Oxbryta (voxelotor) Online

$33,074.12
(0 Reviews)
ISEASE INDICATIONS: Sickle Cell Disease MANUFACTURER: Global Blood Therapeutics, Inc. USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Oxbryta, known by its generic name Voxelotor, is a pharmaceutical medication used to treat a rare genetic blood disorder called sickle cell disease (SCD).

Buy Evrenzo (Roxadustat) Online

From $171.42
(0 Reviews)
DISEASE INDICATIONS: Anemia MANUFACTURER: Astellas Pharma Inc. FibroGen USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Pharmaceuticals and Medical Devices Agency (PMDA) Evrenzo, known by its generic name Roxadustat, is a pharmaceutical medication that belongs to a class of drugs called HIF-PH (Hypoxia-Inducible Factor Prolyl Hydroxylase) inhibitors. This innovative medication is primarily used to treat certain types of anemia, particularly those associated with chronic kidney disease (CKD) and inflammation.

Buy Givlaari (givosiran) Online

(0 Reviews)
DISEASE INDICATIONS: Acute Hepatic Porphyria (AHP) MANUFACTURER: Alnylam Pharmaceuticals USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Givlaari, known by its generic name Givosiran, is a pharmaceutical medication used to treat a rare genetic disorder called acute hepatic porphyria (AHP). This innovative medication represents a significant advancement in the management of this condition, which is characterized by recurrent, severe attacks of abdominal pain, neurological symptoms, and potential life-threatening complications.

Buy Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo) Online

$24,063.64
(0 Reviews)
DISEASE INDICATIONS: Thromboembolism MANUFACTURER: Alexion Pharmaceuticals USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Andexxa, with its generic name coagulation factor Xa (recombinant), inactivated-zhzo, is a specialized medication used in the field of hematology and coagulation medicine. It is primarily designed to address life-threatening bleeding events or complications associated with the use of certain anticoagulant medications, specifically direct or indirect factor Xa inhibitors.

Back to Top
Product has been added to your cart